1008
S. Borowski et al. / Carbohydrate Research 343 (2008) 1004–1011
3
1H, J4,5 9.2 Hz, H-4), 3.31 (s, 3H, OCH3), 2.42 (s, 3H,
CH3C6H4), 2.00 (s, 3H, COCH3); 13C NMR
(2 ꢂ COCH3); EIMS (m/z, %) 473 (5) [M+H]+. Anal.
Calcd for C20H27NO10S (473.14): C, 50.73; H, 5.75;
N, 2.96; S, 6.77. Found: C, 50.54; H, 5.77; N, 2.77; S,
6.70.
(75.47 MHz, CDCl3):
d 172.08 (COCH3), 144.90
(p-C6H4), 132.82 (i-C6H4), 129.88 (m-C6H4), 127.98
(o-C6H4), 98.25 (C-1), 73.61 (C-3), 70.71 (C-4), 69.41
(C-5), 69.19 (C-6), 55.23 (OCH3), 53.45 (C-2), 23.21
(COCH3), 21.62 (CH3C6H4); CIMS (m/z, %) 390 (100)
[M+H]+. Anal. Calcd for C16H23NO8S (389.11): C,
49.35; H, 5.95; N, 3.60; S, 8.23. Found: C, 49.14; H,
5.97; N, 3.46; S, 8.18.
3.6. Methyl 2-acetamido-3,4-di-O-acetyl-2-deoxy-6-O-p-
tolysulfonyl-b-D-glucopyranoside (3b)
Mp 179 °C (ethanol, dec), lit.5 mp 192 °C (dec; this melt-
ing point was not reproducible even after several crystal-
22
23
D
lisations); ½aꢃD +21.8 (c 1.0, CHCl3), lit.5 ½aꢃ +19.7 (c
3.4. Methyl 2-acetamido-2-deoxy-6-O-p-tolysulfonyl-b-D-
glucopyranoside (2b)
0.6, CH2Cl2); Rf 0.34 (ethyl acetate); 1H NMR
(250.13 MHz, CDCl3): d 7.77 (m, 2H, o-C6H4), 7.32
3
(m, 2H, m-C6H4), 5.52 (d, 1H, JNH,2 9.0 Hz, NH),
24
3
3
Colourless crystals (33 mg, 2%); mp 101–102 °C; ½aꢃD
5.22 (dd, 1H, J2,3 10.5 Hz, J3,4 9.3 Hz, H-3), 4.88 (‘t’,
1
3
3
ꢀ30.7 (c 1.0, CHCl3); Rf 0.27 (solvent A1); H NMR
1H, J4,5 10.0 Hz, H-4), 4.50 (d, 1H, J1,2 8.4 Hz, H-1),
4.14–4.02 (m, 2H, H-6), 3.85–3.70 (m, 2H, H-2, H-5),
3.41 (s, 3H, OCH3), 2.44 (s, 3H, CH3C6H4), 2.00, 1.99
(2s, 2 ꢂ 3H, 2 ꢂ COCH3), 1.92 (s, 3H, NHCOCH3);
13C NMR (75.47 MHz, CDCl3): d 170.86 (NHCOCH3),
170.22, 169.47 (2 ꢂ COCH3), 145.15, 132.41 (2 ꢂ
i-C6H4), 129.88, 128.05 (2 ꢂ o-, 2 ꢂ m-C6H4), 101.44
(C-1), 72.10 (C-3), 71.58 (C-5), 68.88 (C-4), 68.01
(C-6), 56.76 (OCH3), 54.41 (C-2), 23.32 (NHCOCH3),
21.65 (CH3C6H4), 20.62, 20.56 (2 ꢂ COCH3); CIMS
(m/z, %) 474 (76) [M+H]+. Anal. Calcd for C20H27-
NO10S (473.14): C, 50.73; H, 5.75; N, 2.96; S, 6.77.
Found: C, 51.04; H, 5.90; N, 2.85; S, 6.48.
For transformation of compounds 3a,b (10.0 g,
21.14 mmol) into methyl 3,4-di-O-acetyl-2-acetamido-
2,6-dideoxy-a,b-D-glucopyranosides (5a,b) via the corres-
ponding iodine compound 4a,b conditions of Kajihara
et al.5 were used again. Purification by column chroma-
tography (eluent ethyl acetate gradient 80?100% in
petrol ether) afforded 5a,b (5.33 g, 83%). Analytical
samples were obtained by column chromatography
using ethyl acetate as eluent.
3
(500.13 MHz, Me2SO-d6): d 7.67 (d, 1H, JNH,2 9.0 Hz,
NH), 7.79 (m, 2H, o-C6H4), 7.48 (m, 2H, m-C6H4),
4.25 (dd, 1H, J6a,6b 10.7 Hz, J5,6a 1.8 Hz, H-6a), 4.17
(d, 1H, J1,2 8.3 Hz, H-1), 4.07 (dd, 1H, J5,6b 6.6 Hz,
2
3
3
3
H-6b), 3.40–3.28 (m, 2H, H-2, H-5), 3.24 (dd, 1H,
3J2,3 10.1 Hz, J3,4 8.5 Hz, H-3), 3.24 (s, 3H, OCH3),
3
3.01 (dd, 1H, 3J4,5 9.2 Hz, H-4), 2.42 (s, 3H, CH3C6H4),
1.79 (s, 3H, COCH3); 13C NMR (125.76 MHz, Me2SO-
d6): d 169.24 (COCH3), 145.10 (p-C6H4), 132.47 (i-
C6H4), 130.31 (m-C6H4), 127.78 (o-C6H4), 101.75 (C-
1), 74.05 (C-3), 73.47 (C-5), 70.27 (C-6), 70.15 (C-4),
55.68 (OCH3), 55.12 (C-2), 23.25 (COCH3), 21.27
(CH3C6H4); CIMS (m/z, %) 390 (2) [M+H]+. Anal.
Calcd for C16H23NO8S (389.11): C, 49.35; H, 5.95;
N, 3.60; S, 8.23. Found: C, 49.55, H, 6.25; N, 3.44; S,
8.36.
Starting from the anomeric mixture of 1a,b
(10.0 g, 43.0 mmol)4 compounds 3a,b (16,7 g, 83%) were
obtained according to a procedure of Kajihara et al.5
Both anomers were separated by flash-chromatography
(ethyl acetate) to provide analytical samples.
3.5. Methyl 2-acetamido-3,4-di-O-acetyl-2-deoxy-6-O-p-
tolysulfonyl-a-D-glucopyranoside (3a)
3.7. Methyl 2-acetamido-3,4-di-O-acetyl-2,6-dideoxy-a-
D-glucopyranoside (5a)
21
23
Mp 67–70 °C; ½aꢃD +87.6 (c 1.0, CHCl3); Rf 0.48 (ethyl
Mp 104–109 °C; ½aꢃD +76.4 (c 1.0, CHCl3); Rf 0.42
1
acetate); 1H NMR (250.13 MHz, CDCl3): d 7.77 (m,
2H, o-C6H4), 7.34 (m, 2H, m-C6H4), 5.65 (d, 1H,
(ethyl acetate); H NMR (300.13 MHz, CDCl3): d 5.69
(d, 1H, JNH,2 9.5 Hz, NH), 5.14 (dd, 1H, J3,4 9.5 Hz,
H-3), 4.82 (‘t’, 1H, J4,5 9.9 Hz, H-4), 4.63 (d, 1H, J1,2
3.6 Hz, H-1), 4.28 (ddd, 1H, J2,3 10.7 Hz, H-2), 3.79
3
3
3
3
3
3JNH,2 9.5 Hz, NH), 5.15 (dd, 1H, J3,4 9.5 Hz, H-3),
3
3
3
4.91 (‘t’, 1H, J4,5 10.0 Hz, H-4), 4.61 (d, 1H, J1,2
3.7 Hz, H-1), 4.21 (ddd, 1H, J2,3 10.7 Hz, H-2), 4.10–
3
3
(dq, 1H, J5,6 6.3 Hz, H-5), 3.36 (s, 3H, OCH3),
3
3
4.01 (m, 2H, H-6), 3.94 (ddd, 1H, J5,6b 3.4 Hz, J5,6a
5.3 Hz, H-5), 3.33 (s, 3H, OCH3), 2.44 (s, 3H,
CH3C6H4), 2.02, 1.98 (2s, 2 ꢂ 3H, 2 ꢂ COCH3), 1.92
(s, 3H, NHCOCH3); 13C NMR (62.89 MHz, CDCl3):
d 171.25, 169.84, 169.34 (3 ꢂ CO), 145.06 (p-C6H4),
132.54 (i-C6H4), 129.81 (m-C6H4), 128.04 (o-C6H4),
97.97 (C-1), 71.00 (C-3), 68.37 (C-4), 67.93 (C-6),
67.52 (C-5), 55.45 (OCH3), 51.66 (C-2), 23.16
(NHCOCH3), 21.64 (CH3C6H4), 20.65, 20.52
2.01, 1.99 (2s, 2 ꢂ 3H, 2 ꢂ COCH3), 1.93 (s, 3H,
NHCOCH3), 1.17 (d, 3H, H-6); 13C NMR
(62.89 MHz, CDCl3):
d
171.42, 169.83, 169.57
(3 ꢂ CO), 98.09 (C-1), 73.30 (C-3), 71.35 (C-4), 65.40
(C-5), 55.17 (OCH3), 52.16 (C-2), 23.20 (NHCOCH3),
20.72, 20.68 (2 ꢂ COCH3), 17.30 (C-6); CIMS (m/z,
%) 304 (87) [M+H]+. Anal. Calcd for C13H21NO7
(303.13): C, 51.48; H, 6.98; N, 4.62. Found: C, 51.42;
H, 7.21; N, 4.45.